Literature DB >> 11078322

Cellular expression of isoforms of endothelin-converting enzyme-1 (ECE-1c, ECE-1b and ECE-1a) and endothelin-converting enzyme-2.

A P Davenport1, R E Kuc.   

Abstract

Our aim was to compare the cellular expression of endothelin-converting enzyme-1 (ECE-1) isoforms and ECE-2 using immunocytochemistry in normal and diseased human tissue. Intense ECE-1b immunoreactivity was present within renal and pulmonary epithelial cells with lower levels of staining displayed by ECE-1c, ECE-1a and ECE-2 antisera. Staining was detected with all antisera (except ECE-1a) within the endothelium of renal and pulmonary vessels having a range of lumen diameters as well as pial arteries and intracerebral vessels penetrating brain. ECE-1b, ECE-1c and ECE-2 immunoreactivity was localized to perivascular astrocytes and neuronal processes in the cerebral cortex. In diseased vessels, ECE-1c, ECE-1b and ECE-2 antisera stained macrophages infiltrating atherosclerotic plaques within coronary arteries. These results suggest ECE-1b and ECE-2 may be widely expressed in normal tissue from humans and inhibition of ECE-1 isoforms and ECE-2 expressed by cells such as macrophages in pathophysiological tissue may be an additional therapeutic target in cardiovascular disease.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11078322     DOI: 10.1097/00005344-200036051-00006

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  13 in total

1.  Macromolecules involved in production and metabolism of beta-amyloid at the brain barriers.

Authors:  Janelle S Crossgrove; Ellen L Smith; Wei Zheng
Journal:  Brain Res       Date:  2007-02-02       Impact factor: 3.252

2.  Androgen alleviates neurotoxicity of β-amyloid peptide (Aβ) by promoting microglial clearance of Aβ and inhibiting microglial inflammatory response to Aβ.

Authors:  Peng-Le Yao; Shu Zhuo; Hong Mei; Xiao-Fang Chen; Na Li; Teng-Fei Zhu; Shi-Ting Chen; Ji-Ming Wang; Rui-Xing Hou; Ying-Ying Le
Journal:  CNS Neurosci Ther       Date:  2017-09-20       Impact factor: 5.243

3.  Animals lacking endothelin-converting enzyme-2 are deficient in learning and memory.

Authors:  R M Rodriguiz; K Gadnidze; A Ragnauth; N Dorr; M Yanagisawa; W C Wetsel; L A Devi
Journal:  Genes Brain Behav       Date:  2008-06       Impact factor: 3.449

Review 4.  Endothelin-converting enzymes and related metalloproteases in Alzheimer's disease.

Authors:  Javier Pacheco-Quinto; Aimee Herdt; Christopher B Eckman; Elizabeth A Eckman
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

5.  Endothelin-1 raises excitability and reduces potassium currents in sensory neurons.

Authors:  Bihua Feng; Gary Strichartz
Journal:  Brain Res Bull       Date:  2009-05-03       Impact factor: 4.077

6.  Endothelin and vascular remodelling in colitis pathogenesis--appendicitis and appendectomy limit colitis by suppressing endothelin pathways.

Authors:  Rajkumar Cheluvappa; Rajaraman Eri; Annie S Luo; Michael C Grimm
Journal:  Int J Colorectal Dis       Date:  2014-08-02       Impact factor: 2.571

7.  Characterization of endothelin-converting enzyme-2. Implication for a role in the nonclassical processing of regulatory peptides.

Authors:  Nino Mzhavia; Hui Pan; Fa-Yun Che; Lloyd D Fricker; Lakshmi A Devi
Journal:  J Biol Chem       Date:  2003-01-30       Impact factor: 5.157

Review 8.  Endothelin receptors and pain.

Authors:  Alla Khodorova; Jean-Pierre Montmayeur; Gary Strichartz
Journal:  J Pain       Date:  2009-01       Impact factor: 5.820

9.  Endothelin-converting enzyme-2 is increased in Alzheimer's disease and up-regulated by Abeta.

Authors:  Jennifer C Palmer; Shabnam Baig; Patrick G Kehoe; Seth Love
Journal:  Am J Pathol       Date:  2009-06-18       Impact factor: 4.307

10.  Local antinociception induced by endothelin-1 in the hairy skin of the rat's back.

Authors:  Saurav Shrestha; Neilia G Gracias; Florence Mujenda; Alla Khodorova; Michael R Vasko; Gary R Strichartz
Journal:  J Pain       Date:  2009-07       Impact factor: 5.820

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.